You are here

brivaracetam

FDA approves expanded indication for UCB’s Briviact to treat pediatric patients

Pharmaceutical Business Review

Tue, 08/31/21 - 10:57 am

partial onset seizures

Belgium's UCB leans on RTP work force for epilepsy drug application

Bizjournals.com

Fri, 01/23/15 - 11:47 am

UCB Reports Phase III Data on Epilepsy Drug, To File in 2015

Yahoo/Zacks.com

Tue, 12/9/14 - 04:05 pm

UCB Pharmaceuticals

UCB inches toward the FDA with its latest epilepsy contender

Fierce Biotech

Thu, 07/24/14 - 09:56 am

UCB Pharmaceuticals